A review of the surgical management of sacral chordoma

European Journal of Surgical Oncology

Volumn 40, Issue 11, 2014, Pages 1412-1420

  Kayani, B ^a   Hanna, S A ^a   Sewell, M D ^a   Saifuddin, A ^a   Molloy, S ^a   Briggs, T W R ^a  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Chordoma; Metastasis; Prognostic factors; Recurrence; Surgical management; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CELL DEDIFFERENTIATION; CHORDOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; LONG TERM SURVIVAL; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS CANCER; PELVIS RADIOGRAPHY; PELVIS SURGERY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SACRAL CHORDOMA; SACRECTOMY; SACROILIAC JOINT; SURGICAL APPROACH; SURGICAL RISK; SYSTEMATIC REVIEW; TREATMENT RESPONSE; WIDE EXCISION; PATHOLOGY; PROGNOSIS; SACRUM; SPINAL NEOPLASMS; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME;

CHORDOMA; HUMANS; NEOPLASM INVASIVENESS; PROGNOSIS; SACRUM; SPINAL NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84922481089     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.04.008     Document Type: Review

References (99)

1. Samson IR, Springfield DS, Suit HD, Mankin HJ. Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Jt Surg Am 1993;75:1476-84.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Mirra J, Nelson S, Della Rocca C. Chordoma. In: Fletcher CD, Unni K, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon, France: IARC Press; 2002, p. 316-7.
4. Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH. Chordoma: the nonsarcoma primary bone tumor. Oncologist 2007;12(11):1344-50.
5. Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Jt Surg Am 2006;88:1532-9.
6. Catton C, O'Sullivan B, Bell R, et al. Chordoma: long-term followup after radical photon irradiation. Radiother Oncol 1996;41:67-72.
7. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson Jr RC. Lumbosacral chordoma. Prognostic factors and treatment. Spine 1999;24:1639-45.
8. Sundaresan N, Huvos AG, Krol G, Lane JM, Brennan M. Surgical treatment of spinal chordomas. Arch Surg 1987;122:1479-82.
9. York JE, Kaczaraj A, Abi-Said D, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 1999;44:74-80.
10. Azzarelli A, Quagliuolo V, Cerasoli S, et al. Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 1988;37:185-91.
11. Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer 1999;85:878-83.
12. Arýel IM, Verdu C. Chordoma: an analysis of twenty cases treated over a twenty-year span. J Surg Oncol 1975;7:27-44.
13. Rich TA, Schiller A, Suit HD, Mankin HJ. Clinical and pathologic review of 48 cases of chordoma. Cancer 1985;56:182-7.
14. Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003;10:291-6.
15. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 2000;88:2122-34.
16. Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Jt Surg Am 2005;87:2211-6.
17. Gunterberg B, Romanus B, Sterner B. Pelvic strength after major amputation of the sacrum: an experimental study. Acta Orthop Scand 1976;47:635-42.
18. Osaka S, Kodoh O, Sugita H, Osaka E, Yoshida Y, Ryu J. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol 2006;132:213-8.
19. Smith J, Ludwig RL, Marcove RC. Sacrococcygeal chordoma. A clinicoradiological study of 60 patients. Skeletal Radiol 1987;16:37-44.
20. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 2001;12:1-11.
21. Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y. Local recurrence after S2-3 sacrectomy in sacral chordoma. Report of four cases. J Neurosurg 2002;97(1 Suppl.):98-101.
22. Ozaki T, Hillmann A, Winkelmann W. Surgical treatment of sacrococcygeal chordoma. J Surg Oncol 1997;64:274-9.
23. Gray SW, Singhabhandhu B, Smith RA, et al. Sacrococcygeal chordoma: report of a case and review of the literature. Surgery 1975;78:573-82.
24. Anson KM, Byrne PO, Robertson ID, Gullan RW, Montgomery AC. Radical excision of sacrococcygeal tumours. Br J Surg 1994;81:460-1.
25. Chandawarkar RY. Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg 1996;20:717-9.
26. Higinbotham NL. Chordoma: a thirty-five year study at the Memorial Hospital. Cancer 1967;20:1841.
27. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012;13:e69-76.
28. Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobile spine: fifty years of experience. Spine 2006;31:493-503.
29. Eriksson B, Gunterberg B, Kindblom LG. Chordoma: a clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand 1981;52:49-58.
30. Soo MY. Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 2001;45:427-34.
31. Kaiser TE, Pritchard DJ, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer 1984;53:2574-8.
32. Ozger A, Eralp L, Sungur M, Atalar AC. Surgical management of sacral chordoma. Acta Orthop Belg 2010;76:243-53.
33. Hanna SA, Aston WJS, Briggs TWR, Cannon SR, Saifuddin FA. Sacral chordoma: can local recurrence after sacrectomy be predicted? Clin Orthop Relat Res 2008;466:2217-23.
34. Huth JF, Dawson EG, Eilber FR. Abdominosacral resection for malignant tumors of the sacrum. Am J Surg 1984;148:157-61.
35. Localio SA, Eng K, Ranson JH. Abdominosacral approach for retrorectal tumors. Ann Siug 1980;191:555-60.
36. Sung HW, Shu WP, Wang HM, Yuai SY, Tsai VB. Surgical treatment of primary tumors of the sacrum. Clin Orthop 1987;215:91-8.
37. Asavamongkolkul A, Waikakul S. Wide resection of sacral chordoma via a posterior approach. Int Orthop (SICOT) 2012;36:607-12.
38. Dahlin DC, MacCarty CS. Chordoma: a study of fifty-nine cases. Cancer 1952;5:1170.
39. MacCarty CS, Waugh JM, Mayo CW, Coventry MB. The surgical treatment of presacral tumors: a combined problem. Mayo Clin Proc 1952;27:73.
40. Hsieh PC, Xu R, Sciubba DM, et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondroarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 2009;34(20):2233-9.
41. Sahakitrungruang C, Chantra K. One-staged subtotal sacrectomy for primary sacral tumor. Ann Surg Oncol 2009;16(9):2594.
42. Puri A, Agarwal MG, Shah M, et al. Decision making in primary sacral tumors. Spine J 2009;9(5):396-403.
43. Stener B, Gutenberg B. High amputation of the sacrum for extirpation of tumors. Principles and technique. Spine 1978;3:351-66.
44. Wuisman P, Harle A, Matthiass HH, Roessner A, Erlemann R, Reiser M. Two-stage therapy in the treatment of sacral tumors. Arch Orthop Trauma Surg 1989;108:255-60.
45. Yang H, Zhu L, Ebraheim NA, et al. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization. Spine J 2009;9(12):972-80.
46. Chen KW, Yang HL, Liu J, Chen XQ. Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord 2010;48:166-71.
47. Ferraresi V, Nuzzo C, Zoccali C, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer 2010;10:22.
48. Lee J, Bhatia N, Hoang B, Ziogas A, Zell J. Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. J Bone Jt Surg Am 2012;94:356-63.
49. Hosalkar HS, Jones KJ, King JJ. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine (Phila Pa 1976) 2007;32:1107-15.
50. Larsson SE, Lorentzon R, Boquist L. Giant cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Jt Surg Am 1975;57:167-73.
51. Randall RL, Bruckner J, Lloyd C, Pohlman TH. Conrad EU 3rd. Sacral resection and reconstruction for tumors and tumor-like conditions. Orthopedics 2005;28:307-13.
52. Kayani B, Zacharakis, Ahmed K, Hanna GB. Lymph node metastases and prognosis in oesophageal carcinomaea systematic review. Eur J Surg Oncol 2011 Sep; 37(9):747-53.
53. Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ. The surgical management of sacral chordomas. Spine (Phila Pa 1976) 2009;34:2700-4.
54. Miles WK, Chang DW, Kroll SS, et al. Reconstruction of large sacral defects following total sacrectomy. Plast Reconstr Surg 2000;105:2387-94.
55. Ahmed AR. Safety margins in resection of sacral chordoma: analysis of 18 patients. Arch Orthop Trauma Surg 2009;129:483-7.
56. Gokaslan ZL, Romsdahl MM, Kroll SS, et al. Total sacrectomy and Galveston L-rod reconstruction for malignant neoplasms. Technical note. J Neurosurg 1997;87:781-7.
57. Jackson RJ, Gokaslan ZL. Spinal-pelvic fixation in patients with lumbosacral neoplasms. J Neurosurg (Spine 1) 1987;92:61-70. 200037-44.
58. Morimitsu Y, Aoki T, Yokoyama K, Hashimoto H. Sarcomatoid chordoma: chordoma with a massive spindle cell component. Skeletal Radiol 2000;29:721-5. 22.
59. Hruban RH, May M, Marcove RC, Huvos AG. Lumbo-sacral chordoma with high-grade malignant cartilaginous and spindle cell components. Am J Surg Pathol 1990;14:384-9.
60. Halpern J, Kopolovic J, Catane R. Malignant fibrous histiocytoma developing in irriadiated sacral chordoma. Cancer 1984;53:2661-2.
61. Choi YJ, Kim TS. Malignant fibrous histiocytoma in chordoma: immunohistological evidence of transformation from chordoma to malignant fibrous histiocytoma. Yonsei Med J 1994;35:239-43.
62. Fukuda T, Aihara T, Ban S, Nakajima T, Machinami R. Sacrococcygeal chordoma with malignant spindle cell component: a report of two autopsy cases with a review of the literature. Acta Pathol Jpn 1992;42:448-53.
63. Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. "Dedifferentiated" chordoma: a clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol 1987;11:516-25.
64. Bisceglia M, D'Angelo VA, Guglielmi G, Dor DB, Pasguinelli. Dedifferentiated chordoma of the thoracic spine with rhabdomyosarcomatous differentiations: report of a case and review of the literature. Ann Diagn Pathol 2007;11:262-73.
65. Kishikawa H, Tanaka K. Chordoma: report of an autopsy case with fi; brosarcoma. Acta Pathol Jpn 1974;24:299-308.
66. Hanna SA, Tirabosco R, Amin A, et al. Dedifferentiated chordoma: a report of four cases arising "de novo". J Bone Jt Surg Br 2008 May; 90(5):652-6.
67. Volpe R, Mazabraud A. A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol 1983;7:161-70.
68. MacSweeney F, Darby A, Saifuddin A. Dedifferentiated chondrosarcoma of the appendicular skeleton: MRI-pathological correlation. Skeletal Radiol 2003;32:671-8.
69. Gunterberg B, Norlen L, Stener B, Sundin T. Neurourologic evaluation after resection of the sacrum. Invest Urol 1975;13:183-8.
70. Gunterberg B, Kewenter J, Petersen I, Stener B. Anorectal function after major resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves. Br J Surg 1976;63:546-54.
71. Todd Jr LT, Yaszemski MJ, Currier BL, Fuchs B, Kim CW, Sim FH. Bowel and bladder function after major sacral resection. Clin Orthop Relat Res 2002;397:36-9.
72. Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus 2003;15:9.
73. Sundaresan N, Galicich JH, Chu FC, Huvos AG. Spinal chordomas. J Neurosurg 1979;50:312-9.
74. Unni KK. Dahlin's bone tumors: general aspects and data on 11, 087 cases. 5th ed. Philadelphia: Lippincott-Raven; 1996, p. 291-305.
75. Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol 2007;19:367-70.
76. Tai PT, Craighead P, Bagdon F. Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques. Cancer 1995;75:749-56.
77. Forsyth PA, Cascino TL, Shaw EG, et al. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 1993;78:741-7.
78. Cummings BJ, Hodson DI, Bush RS. Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 1983;9:633-42.
79. Akmal S, Ole SN, Anne GJ, Johnny K, Ernst RW, Bjarne L. A retrospective clinicopathological study of 37 patients with chordoma: a Danish national series. Sarcoma 1997;1:161-5.
80. Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Jt Surg Am 2008;90:62-9.
81. Moojen WAMD, Vleggeert-Lankamp CLA, Krol ADG, Dijkstra SPD. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable. Spine 36(10):E656-61.
82. Suit HD, Goitein M, Munzenrider J, et al. Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg 1982;56:377-85.
83. Austin-Seymour M, Munzenrider JE, Goitein M, et al. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res Suppl 1985;8:219-26.
84. Austin-Seymour M, Munzenrider J, Linggood R, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 1990;13:327-30.
85. Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989;70:13-7.
86. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995;31:577-81.
87. Berson AM, Castro JR, Petti P, et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 1988;15:559-65.
88. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91:432-9.
89. Nishida Y, Kamada T, Imai R, et al. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. Int J Radiat Oncol Biol Phys 2011;79:110-6.
90. Chugh R, Dunn R, Zalupski MM, et al. Phase II study of 9-nitrocamptothecin in patients with advanced chordoma or soft tissue sarcoma. J Clin Oncol 2005;23:3597-604.
91. Fleming GF, Heimann PS, Stephens JK, et al. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 1993;72:714-8.
92. Negri T, Casieri P, Miselli F, et al. Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient. Br J Cancer 2007;96:180-1.
93. Casali PG, Messina A, Stacchiotti S, et al. Imatinib mesylate in chordoma. Cancer 2004;101:2086-97.
94. Stacchiotti S, Marrari A, Tamborini E, et al. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 2009;20:1886-94.
95. George S, Merriam P, Maki RG, et al. Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 2009;27:3154-60.
96. Casali PG, Stacchiotti S, Grosso F, et al. Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma. J Clin Oncol 2007;25 (18 Suppl.). Abstract 10038.
97. Weinberger PM, Yu Z, Kowalski D, et al. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg 2005;131:707-11.
98. Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 2006;29:572-4.
99. Singhal N, Kotasek D, Parnis FX. Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs 2009;20:953-5.